News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
381,936 Results
Type
Article (23908)
Company Profile (313)
Press Release (357715)
Section
Business (112385)
Career Advice (708)
Deals (20362)
Drug Delivery (54)
Drug Development (62840)
Employer Resources (88)
FDA (8853)
Job Trends (7829)
News (202640)
Policy (15997)
Tag
Academia (1668)
Alliances (30433)
Alzheimer's disease (935)
Approvals (8815)
Artificial intelligence (82)
Bankruptcy (154)
Best Places to Work (6502)
Biotechnology (251)
Breast cancer (82)
Cancer (810)
Cardiovascular disease (71)
Career advice (593)
Cell therapy (186)
Clinical research (50143)
Collaboration (273)
Compensation (99)
COVID-19 (1680)
C-suite (71)
Cystic fibrosis (67)
Data (900)
Diabetes (109)
Diagnostics (2551)
Earnings (39395)
Employer resources (81)
Events (61013)
Executive appointments (222)
FDA (9198)
Funding (270)
Gene therapy (157)
GLP-1 (481)
Government (1909)
Healthcare (10555)
Infectious disease (1735)
Inflammatory bowel disease (102)
Interviews (115)
IPO (9484)
Job creations (1613)
Job search strategy (534)
Layoffs (233)
Legal (2963)
Lung cancer (126)
Manufacturing (107)
Medical device (5247)
Medtech (5250)
Mergers & acquisitions (10985)
Metabolic disorders (306)
Neuroscience (1156)
NextGen Class of 2024 (3499)
Non-profit (2181)
Northern California (1027)
Obesity (173)
Opinion (120)
Patents (63)
People (35565)
Phase I (15857)
Phase II (22464)
Phase III (16301)
Pipeline (353)
Postmarket research (1670)
Preclinical (6657)
Radiopharmaceuticals (215)
Rare diseases (177)
Real estate (2594)
Regulatory (11960)
Research institute (1526)
Resumes & cover letters (94)
Southern California (934)
Startups (2554)
United States (8833)
Vaccines (355)
Weight loss (116)
Date
Today (89)
Last 7 days (649)
Last 30 days (2531)
Last 365 days (24989)
2024 (22662)
2023 (27542)
2022 (34699)
2021 (36633)
2020 (32624)
2019 (26047)
2018 (19485)
2017 (20124)
2016 (18425)
2015 (22253)
2014 (16170)
2013 (12181)
2012 (12613)
2011 (12909)
2010 (11925)
Location
Africa (348)
Arizona (68)
Asia (24582)
Australia (4269)
California (2316)
Canada (833)
China (183)
Colorado (96)
Connecticut (100)
Europe (62700)
Florida (261)
Georgia (87)
Illinois (194)
Indiana (105)
Kansas (63)
Maryland (376)
Massachusetts (1862)
Michigan (69)
Minnesota (129)
New Jersey (651)
New York (698)
North Carolina (487)
Northern California (1027)
Ohio (87)
Pennsylvania (504)
South America (528)
Southern California (934)
Texas (281)
Washington State (262)
381,936 Results for "peptide therapeutics group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics
Secarna Pharmaceuticals GmbH & Co. KG and Orbit Discovery Ltd. today announced that they have entered into a collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide (ASO) therapeutics.
May 28, 2024
·
2 min read
Hemogenyx Pharmaceuticals PLC Announces Operations Update - June 17, 2024
Hemogenyx Pharmaceuticals plc, the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its ongoing activities and progress.
June 17, 2024
·
4 min read
Press Releases
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
October 7, 2024
·
3 min read
Press Releases
Coave Therapeutics Showcases Breakthrough in Peptide-Based Conjugated AAV Vectors Using ALIGATER™ Platform in a Late-Breaking Abstract at ESGCT 2024
October 22, 2024
·
3 min read
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked first in overall corporate reputation among rare disease patient groups around the world who were familiar with the company.
August 23, 2023
·
4 min read
Press Releases
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit
October 9, 2024
·
1 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
November 11, 2024
·
3 min read
Genetown
Bicycle Therapeutics to Participate in Upcoming June 2024 Investor Conferences
Bicycle Therapeutics plc, a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will participate in the following investor conferences in June.
June 3, 2024
·
2 min read
Drug Development
Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024
Avacta Group plc announces updated clinical data from the First-in-Human Phase 1 trial of the peptide drug conjugate, AVA6000 will be presented at the 2024 American Association for Cancer Research Annual Meeting, taking place in San Diego, California from 5-10 April 2024.
March 5, 2024
·
3 min read
Press Releases
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer
October 15, 2024
·
3 min read
1 of 38,194
Next
